Serological Evidence of Exposure to Onyong-Nyong and Chikungunya Viruses in Febrile Patients of Rural Taita-Taveta County and Urban Kibera Informal Settlement in Nairobi, Kenya
Several alphaviruses, such as chikungunya (CHIKV) and Onyong-nyong (ONNV), are endemic in Kenya and often cause outbreaks in different parts of the country. We assessed the seroprevalence of alphaviruses in patients with acute febrile illness in two geographically distant areas in Kenya with no previous record of alphavirus outbreaks. Blood samples were collected from febrile patients in health facilities located in the rural Taita-Taveta County in 2016 and urban Kibera informal settlement in Nairobi in 2017 and tested for CHIKV IgG and IgM antibodies using an in-house immunofluorescence assay (IFA) and a commercial ELISA test, respectively. A subset of CHIKV IgG or IgM antibody-positive samples were further analyzed using plaque reduction neutralization tests (PRNT) for CHIKV, ONNV, and Sindbis virus. Out of 537 patients, 4 (0.7%) and 28 (5.2%) had alphavirus IgM and IgG antibodies, respectively, confirmed on PRNT. We show evidence of previous and current exposure to alphaviruses based on serological testing in areas with no recorded history of outbreaks.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:14 |
---|---|
Enthalten in: |
Viruses - 14(2022), 6 vom: 13. Juni |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Masika, Moses Muia [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 27.06.2022 Date Revised 21.07.2022 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.3390/v14061286 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM342678418 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM342678418 | ||
003 | DE-627 | ||
005 | 20231226014657.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3390/v14061286 |2 doi | |
028 | 5 | 2 | |a pubmed24n1142.xml |
035 | |a (DE-627)NLM342678418 | ||
035 | |a (NLM)35746757 | ||
035 | |a (PII)1286 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Masika, Moses Muia |e verfasserin |4 aut | |
245 | 1 | 0 | |a Serological Evidence of Exposure to Onyong-Nyong and Chikungunya Viruses in Febrile Patients of Rural Taita-Taveta County and Urban Kibera Informal Settlement in Nairobi, Kenya |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 27.06.2022 | ||
500 | |a Date Revised 21.07.2022 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Several alphaviruses, such as chikungunya (CHIKV) and Onyong-nyong (ONNV), are endemic in Kenya and often cause outbreaks in different parts of the country. We assessed the seroprevalence of alphaviruses in patients with acute febrile illness in two geographically distant areas in Kenya with no previous record of alphavirus outbreaks. Blood samples were collected from febrile patients in health facilities located in the rural Taita-Taveta County in 2016 and urban Kibera informal settlement in Nairobi in 2017 and tested for CHIKV IgG and IgM antibodies using an in-house immunofluorescence assay (IFA) and a commercial ELISA test, respectively. A subset of CHIKV IgG or IgM antibody-positive samples were further analyzed using plaque reduction neutralization tests (PRNT) for CHIKV, ONNV, and Sindbis virus. Out of 537 patients, 4 (0.7%) and 28 (5.2%) had alphavirus IgM and IgG antibodies, respectively, confirmed on PRNT. We show evidence of previous and current exposure to alphaviruses based on serological testing in areas with no recorded history of outbreaks | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a ELISA | |
650 | 4 | |a Onyong-nyong | |
650 | 4 | |a alphavirus | |
650 | 4 | |a arbovirus | |
650 | 4 | |a chikungunya | |
650 | 4 | |a febrile illness | |
650 | 4 | |a immunofluorescence | |
650 | 4 | |a neutralization | |
650 | 4 | |a seroprevalence | |
650 | 7 | |a Antibodies, Viral |2 NLM | |
650 | 7 | |a Immunoglobulin G |2 NLM | |
650 | 7 | |a Immunoglobulin M |2 NLM | |
700 | 1 | |a Korhonen, Essi M |e verfasserin |4 aut | |
700 | 1 | |a Smura, Teemu |e verfasserin |4 aut | |
700 | 1 | |a Uusitalo, Ruut |e verfasserin |4 aut | |
700 | 1 | |a Ogola, Joseph |e verfasserin |4 aut | |
700 | 1 | |a Mwaengo, Dufton |e verfasserin |4 aut | |
700 | 1 | |a Jääskeläinen, Anne J |e verfasserin |4 aut | |
700 | 1 | |a Alburkat, Hussein |e verfasserin |4 aut | |
700 | 1 | |a Gwon, Yong-Dae |e verfasserin |4 aut | |
700 | 1 | |a Evander, Magnus |e verfasserin |4 aut | |
700 | 1 | |a Anzala, Omu |e verfasserin |4 aut | |
700 | 1 | |a Vapalahti, Olli |e verfasserin |4 aut | |
700 | 1 | |a Huhtamo, Eili |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Viruses |d 2009 |g 14(2022), 6 vom: 13. Juni |w (DE-627)NLM192382764 |x 1999-4915 |7 nnns |
773 | 1 | 8 | |g volume:14 |g year:2022 |g number:6 |g day:13 |g month:06 |
856 | 4 | 0 | |u http://dx.doi.org/10.3390/v14061286 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 14 |j 2022 |e 6 |b 13 |c 06 |